REFERENCES
- Shafran SD, Singer J, Zarowny DP, et al. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group. N Engl J Med. 1996;335:377–383.
- Pierce M, Crampton S, Henry D, et al. A randomized trial of clarithromycin as prophylaxis against disseminated Myco-bacterium avium complex infection in patients with ad-vanced acquired immunodeficiency syndrome. N Engl J Med. 1996;335:384–391.
- Chaisson RE, Benson CA, Dube MP, et al. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team. Ann Intern Med. 1994;121:905–911.
- Cohn DL, Fisher EJ, Peng GT, et al. A prospective random-ized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clini-cal Research on AIDS. Clin Infect Dis. 1999;29:125–133.
- Guay DR, Gustayson LE, Devcich KJ, Zhang J, Cao G, Olson CA. Pharmacokinetics and tolerability of extended-release clarithromycin. Clin Ther. 2001;23:566–577.
- Murray JJ, Solomon E, McCluskey D, Zhang J, Palmer R, Notario G. Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of adult patients with acute maxillary sinusitis. Clin Ther. 2000;22:1421–1432.
- Weiss K, Vanjaka A, Canadian Clarithromycin Study Group on Bronchitis. An open-label, randomized, multicenter, comparative study of the efficacy and safety of 7 days of treatment with clarithromycin extended-release tablets versus clarithromycin immediate-release tablets for the treatment of patients with acute bacterial exacerbation of chronic bronchitis. Clin Ther. 2002;24:2105–2122.
- Lacy MK, Owens RC Jr, Xu X, Nicolau DP, Quintiliani R, Nightingale CH. Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and cefuroxime axetil against Streptococcus pneumoniae. Int J Antimicrob Agents. 1998;10:279–283.
- Schuirmann DJ. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavai lability. J Pharmacokinetics Biopharmaceutics. 1987;15:657–680.
- Chu S-Y, Wilson S, Deaton RL, Mackenthum AV, Eason CN, Cavanaugh JH. Single- and multiple-dose pharmaco-kinetics of clarithromycin, a new macrolide antimicrobial. J Clin PharmacoL 1993;33:719–726.
- Bui KQ, McNabb J, Li C, Nightingale CH, Nicolau DP. Mononuclear and polymorphonuclear leukocyte disposi-tions of clarithromycin and azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis. Antimicrob Agents Chemother. 1999;43(9):2302–2304.
- Amsden GW, Peloquin CA, Berning SE. The role of ad-vanced generation macrolides in the prophylaxis and treat-ment of Mycobacterium avium complex (MAC) infections. Drugs. 1997;54:69–80.
- Inderlied CB, Kemper CA, Bermudez LE. The Mycobacte-rium avium complex. Clin Microbiol Rev. 1993;6:266–310.
- Perronne C, Gikas A, Truffot-Pernot C, Grosset J, Pocidalo JJ, Vilde JL. Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multipli-cation within human macrophages. Antimicrob Agents Chemother. 1990;34:1508–1511.
- Rastogi N, Labrousse V. Extracellular and intracellular activi-ties of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex. Antimicrob Agents Chemother. 199135: 462–470.
- Cohen Y, Perronne C, Truffot-Pernot C, Grosset J, Vilde JL, Pocidalo JJ. Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against My-cobacterium avium complex in human macrophages. Antimicrob Agents Chemother. 1992;36:2104–2107.
- Ouellet D, Hsu A, Granneman GR, Carlson G, Cavanaugh J, Guenther H, Leonard JM. Pharmacokinetic interaction between ritonavir and clarithromycin. Clin Pharmacol Ther. 1998;64(4):355–362.